Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
Status:
Recruiting
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
This research study is studying a combination of two drug interventions called rosuvastatin
and enoxaparin as a possible preventative measure against developing venous blood clots (such
deep vein thrombosis or pulmonary embolism). .
The drugs involved in this study are:
- Rosuvastatin, also known as Crestor
- Enoxaparin
Phase:
Phase 2
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) National Institutes of Health (NIH)